Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
6
×
rna
6
×
boston blog main
national top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
boston top stories
clinical trials
new york blog main
new york top stories
startups
texas blog main
texas top stories
arena pharmaceuticals
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
deals
detroit blog main
detroit top stories
editas medicine
fda
financing
gene therapy
hemophilia
indiana blog main
indiana top stories
ipo
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
vc
venture capital
What
medicine
bio
gene
help
ipo
long
medicines
roundup
scientists
acquisitions
advance
alike
announced
antonio
arena’s
badylak
beam
biologics
bounty
cas
ceo
cig
collabs
comeback
companies
considered
corner
covid
crispr
crude
cutting
daniel
deal
deals
deliver
delivered
despite
diseases
dreamed
drugs
Language
unset
Current search:
rna
×
" national blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
5 years ago
San Antonio to Honor Regenerative Medicine Pioneer Stephen Badylak
@xconomy.com
5 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
6 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M